A citation-based method for searching scientific literature

Michaela Kuhlen, Kirsten Bleckmann, Anja Möricke, Martin Schrappe, Simon Vieth, Gabriele Escherich, Annika Bronsema, Annika Vonalt, Manon Queudeville, C Michel Zwaan, Martin Ebinger, Klaus-Michael Debatin, Thomas Klingebiel, Ewa Koscielniak, Claudia Rossig, Birgit Burkhardt, Reinhard Kolb, Cornelia Eckert, Arndt Borkhardt, Arend von Stackelberg, Christiane Chen-Santel. Br J Haematol 2017
Times Cited: 15







List of co-cited articles
64 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children's Oncology Group.
Stacey L Berg, Susan M Blaney, Meenakshi Devidas, Tom A Lampkin, Anthony Murgo, Mark Bernstein, Amy Billett, Joanne Kurtzberg, Greg Reaman, Paul Gaynon,[...]. J Clin Oncol 2005
195
33

Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801.
Daniel J DeAngelo, Daohai Yu, Jeffrey L Johnson, Steven E Coutre, Richard M Stone, Alison T Stopeck, Jon P Gockerman, Beverly S Mitchell, Frederick R Appelbaum, Richard A Larson. Blood 2007
181
33

Safe integration of nelarabine into intensive chemotherapy in newly diagnosed T-cell acute lymphoblastic leukemia: Children's Oncology Group Study AALL0434.
Stuart S Winter, Kimberly P Dunsmore, Meenakshi Devidas, Nancy Eisenberg, Barbara L Asselin, Brent L Wood, Marcia S Leonard Rn, John Murphy, Julie M Gastier-Foster, Andrew J Carroll,[...]. Pediatr Blood Cancer 2015
53
26

Safety and efficacy of nelarabine in children and young adults with relapsed or refractory T-lineage acute lymphoblastic leukaemia or T-lineage lymphoblastic lymphoma: results of a phase 4 study.
Christian Michel Zwaan, Jerzy Kowalczyk, Claudine Schmitt, Bella Bielorai, Mark W Russo, Mary Woessner, Sulabha Ranganathan, Guy Leverger. Br J Haematol 2017
15
26

Pilot study of nelarabine in combination with intensive chemotherapy in high-risk T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Kimberly P Dunsmore, Meenakshi Devidas, Stephen B Linda, Michael J Borowitz, Naomi Winick, Stephen P Hunger, William L Carroll, Bruce M Camitta. J Clin Oncol 2012
52
26

Acute Lymphoblastic Leukemia in Children.
Stephen P Hunger, Charles G Mullighan. N Engl J Med 2015
890
26

Children's Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia.
Kimberly P Dunsmore, Stuart S Winter, Meenakshi Devidas, Brent L Wood, Natia Esiashvili, Zhiguo Chen, Nancy Eisenberg, Nikki Briegel, Robert J Hayashi, Julie M Gastier-Foster,[...]. J Clin Oncol 2020
55
26

Phase I study of 506U78 administered on a consecutive 5-day schedule in children and adults with refractory hematologic malignancies.
J Kurtzberg, T J Ernst, M J Keating, V Gandhi, J P Hodge, D F Kisor, J J Lager, C Stephens, J Levin, T Krenitsky,[...]. J Clin Oncol 2005
117
20


Irreversible neurological defects in the lower extremities after haploidentical stem cell transplantation: possible association with nelarabine.
Manabu Kawakami, Kyoko Taniguchi, Satoshi Yoshihara, Shinichi Ishii, Katsuji Kaida, Kazuhiro Ikegame, Masaya Okada, Shohei Watanabe, Takuya Nishina, Hidefumi Hamada,[...]. Am J Hematol 2013
23
20

Management of adults with T-cell lymphoblastic leukemia.
David I Marks, Clare Rowntree. Blood 2017
79
20

Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia.
Deepa Bhojwani, Noah D Sabin, Deqing Pei, Jun J Yang, Raja B Khan, John C Panetta, Kevin R Krull, Hiroto Inaba, Jeffrey E Rubnitz, Monika L Metzger,[...]. J Clin Oncol 2014
171
20

Improved Survival for Children and Young Adults With T-Lineage Acute Lymphoblastic Leukemia: Results From the Children's Oncology Group AALL0434 Methotrexate Randomization.
Stuart S Winter, Kimberly P Dunsmore, Meenakshi Devidas, Brent L Wood, Natia Esiashvili, Zhiguo Chen, Nancy Eisenberg, Nikki Briegel, Robert J Hayashi, Julie M Gastier-Foster,[...]. J Clin Oncol 2018
93
20

Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.
Andrew P Weng, Adolfo A Ferrando, Woojoong Lee, John P Morris, Lewis B Silverman, Cheryll Sanchez-Irizarry, Stephen C Blacklow, A Thomas Look, Jon C Aster. Science 2004
20

Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma.
Marcelo C Pasquini, Zhen-Huan Hu, Kevin Curran, Theodore Laetsch, Frederick Locke, Rayne Rouce, Michael A Pulsipher, Christine L Phillips, Amy Keating, Matthew J Frigault,[...]. Blood Adv 2020
116
20

Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.
Shannon L Maude, Theodore W Laetsch, Jochen Buechner, Susana Rives, Michael Boyer, Henrique Bittencourt, Peter Bader, Michael R Verneris, Heather E Stefanski, Gary D Myers,[...]. N Engl J Med 2018
20

Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study.
Christina Peters, Jean-Hugues Dalle, Franco Locatelli, Ulrike Poetschger, Petr Sedlacek, Jochen Buechner, Peter J Shaw, Raquel Staciuk, Marianne Ifversen, Herbert Pichler,[...]. J Clin Oncol 2021
63
20

Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
Birgit Burkhardt, Alfred Reiter, Eva Landmann, Peter Lang, Lisa Lassay, Roswitha Dickerhoff, Max Lakomek, Günter Henze, Arend von Stackelberg. J Clin Oncol 2009
104
13

Complete paraplegia after nelarabine treatment in a T-cell acute lymphoblastic leukemia adult patient.
Cristina Papayannidis, Ilaria Iacobucci, Maria Chiara Abbenante, Antonio Curti, Stefania Paolini, Sarah Parisi, Michele Baccarani, Giovanni Martinelli. Am J Hematol 2010
23
13

Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia.
Hagop M Kantarjian, Daniel J DeAngelo, Matthias Stelljes, Giovanni Martinelli, Michaela Liedtke, Wendy Stock, Nicola Gökbuget, Susan O'Brien, Kongming Wang, Tao Wang,[...]. N Engl J Med 2016
700
13

Chimeric antigen receptor T cells for sustained remissions in leukemia.
Shannon L Maude, Noelle Frey, Pamela A Shaw, Richard Aplenc, David M Barrett, Nancy J Bunin, Anne Chew, Vanessa E Gonzalez, Zhaohui Zheng, Simon F Lacey,[...]. N Engl J Med 2014
13

A T-cell-directed chimeric antigen receptor for the selective treatment of T-cell malignancies.
Maksim Mamonkin, Rayne H Rouce, Haruko Tashiro, Malcolm K Brenner. Blood 2015
160
13

Incidence and prognostic relevance of genetic variations in T-cell lymphoblastic lymphoma in childhood and adolescence.
Bettina R Bonn, Marius Rohde, Martin Zimmermann, David Krieger, Ilske Oschlies, Felix Niggli, Grazyna Wrobel, Andishe Attarbaschi, Gabriele Escherich, Wolfram Klapper,[...]. Blood 2013
73
13

Results and conclusions of the European Intergroup EURO-LB02 trial in children and adolescents with lymphoblastic lymphoma.
Eva Landmann, Birgit Burkhardt, Martin Zimmermann, Ulrike Meyer, Wilhelm Woessmann, Wolfram Klapper, Grazyna Wrobel, Angelo Rosolen, Marta Pillon, Gabriele Escherich,[...]. Haematologica 2017
32
13

Clinical impact of NOTCH1 and/or FBXW7 mutations, FLASH deletion, and TCR status in pediatric T-cell lymphoblastic lymphoma.
Celine Callens, Frederic Baleydier, Etienne Lengline, Raouf Ben Abdelali, Arnaud Petit, Patrick Villarese, Agata Cieslak, Veronique Minard-Colin, Anne Rullier, Anne Moreau,[...]. J Clin Oncol 2012
80
13

Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemia.
Karen L Bride, Tiffaney L Vincent, Soo-Yeon Im, Richard Aplenc, David M Barrett, William L Carroll, Robin Carson, Yunfeng Dai, Meenakshi Devidas, Kimberly P Dunsmore,[...]. Blood 2018
102
13

Report of severe neurotoxicity with cyclophosphamide.
R Nagarajan, C Peters, P Orchard, N Rydholm. J Pediatr Hematol Oncol 2000
6
33

Oxidative stress and nerve damage: role in chemotherapy induced peripheral neuropathy.
Aparna Areti, Veera Ganesh Yerra, Vgm Naidu, Ashutosh Kumar. Redox Biol 2014
210
13

The double-edged sword: Neurotoxicity of chemotherapy.
Rajiv S Magge, Lisa M DeAngelis. Blood Rev 2015
72
13

A reversible posterior leukoencephalopathy syndrome.
J Hinchey, C Chaves, B Appignani, J Breen, L Pao, A Wang, M S Pessin, C Lamy, J L Mas, L R Caplan. N Engl J Med 1996
13

Acute and sub-acute neurological toxicity in children treated for acute lymphoblastic leukemia.
Natalia C Millan, Analía Pastrana, Myriam R Guitter, Pedro A Zubizarreta, María S Monges, María S Felice. Leuk Res 2018
19
13

Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia.
Arend von Stackelberg, Franco Locatelli, Gerhard Zugmaier, Rupert Handgretinger, Tanya M Trippett, Carmelo Rizzari, Peter Bader, Maureen M O'Brien, Benoît Brethon, Deepa Bhojwani,[...]. J Clin Oncol 2016
333
13

L-asparaginase-provoked seizures as singular expression of central nervous toxicity.
M Y Hamdan, E P Frenkel, R Bick. Clin Appl Thromb Hemost 2000
5
40

Effectiveness of high-dose methotrexate in T-cell lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma: a randomized study by the Children's Oncology Group (POG 9404).
Barbara L Asselin, Meenakshi Devidas, Chenguang Wang, Jeanette Pullen, Michael J Borowitz, Robert Hutchison, Steven E Lipshultz, Bruce M Camitta. Blood 2011
109
13

Dexamethasone and High-Dose Methotrexate Improve Outcome for Children and Young Adults With High-Risk B-Acute Lymphoblastic Leukemia: A Report From Children's Oncology Group Study AALL0232.
Eric C Larsen, Meenakshi Devidas, Si Chen, Wanda L Salzer, Elizabeth A Raetz, Mignon L Loh, Leonard A Mattano, Catherine Cole, Alisa Eicher, Maureen Haugan,[...]. J Clin Oncol 2016
204
13

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.
R Peto, M C Pike, P Armitage, N E Breslow, D R Cox, S V Howard, N Mantel, K McPherson, J Peto, P G Smith. Br J Cancer 1977
13

Frequency and clinical significance of cytogenetic abnormalities in pediatric T-lineage acute lymphoblastic leukemia: a report from the Children's Cancer Group.
N A Heerema, H N Sather, M G Sensel, P Kraft, J B Nachman, P G Steinherz, B J Lange, R S Hutchinson, G H Reaman, M E Trigg,[...]. J Clin Oncol 1998
75
13

Recent Advances in the Biology and Treatment of T Cell Acute Lymphoblastic Leukemia.
Mehrdad Hefazi, Mark R Litzow. Curr Hematol Malig Rep 2018
34
13

Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study.
Martin Schrappe, Maria Grazia Valsecchi, Claus R Bartram, André Schrauder, Renate Panzer-Grümayer, Anja Möricke, Rosanna Parasole, Martin Zimmermann, Michael Dworzak, Barbara Buldini,[...]. Blood 2011
256
13

Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial.
Ajay Vora, Nick Goulden, Rachel Wade, Chris Mitchell, Jeremy Hancock, Rachael Hough, Clare Rowntree, Sue Richards. Lancet Oncol 2013
298
13

Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group.
Stephen P Hunger, Xiaomin Lu, Meenakshi Devidas, Bruce M Camitta, Paul S Gaynon, Naomi J Winick, Gregory H Reaman, William L Carroll. J Clin Oncol 2012
699
13

Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000.
Anja Möricke, Martin Zimmermann, Maria Grazia Valsecchi, Martin Stanulla, Andrea Biondi, Georg Mann, Franco Locatelli, Giovanni Cazzaniga, Felix Niggli, Maurizio Aricò,[...]. Blood 2016
134
13

Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia.
Elaine Coustan-Smith, Charles G Mullighan, Mihaela Onciu, Frederick G Behm, Susana C Raimondi, Deqing Pei, Cheng Cheng, Xiaoping Su, Jeffrey E Rubnitz, Giuseppe Basso,[...]. Lancet Oncol 2009
574
13

Nelarabine: a novel purine antimetabolite antineoplastic agent.
Larry W Buie, Stacy S Epstein, Celeste M Lindley. Clin Ther 2007
28
13

Outcome for children and young people with Early T-cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003.
Katharine Patrick, Rachel Wade, Nick Goulden, Chris Mitchell, Anthony V Moorman, Clare Rowntree, Sarah Jenkinson, Rachael Hough, Ajay Vora. Br J Haematol 2014
131
13

The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson Cancer Center experience.
P Jain, H Kantarjian, F Ravandi, D Thomas, S O'Brien, T Kadia, J Burger, G Borthakur, N Daver, E Jabbour,[...]. Leukemia 2014
38
13


Influence of Cranial Radiotherapy on Outcome in Children With Acute Lymphoblastic Leukemia Treated With Contemporary Therapy.
Ajay Vora, Anita Andreano, Ching-Hon Pui, Stephen P Hunger, Martin Schrappe, Anja Moericke, Andrea Biondi, Gabriele Escherich, Lewis B Silverman, Nicholas Goulden,[...]. J Clin Oncol 2016
61
13

Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia.
Bianca D Santomasso, Jae H Park, Darin Salloum, Isabelle Riviere, Jessica Flynn, Elena Mead, Elizabeth Halton, Xiuyan Wang, Brigitte Senechal, Terence Purdon,[...]. Cancer Discov 2018
373
13



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.